Ribavirin

interferon alpha 1 ; Homo sapiens







377 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 34307188 Interferon-lambda 3 and 4 Polymorphisms Increase Sustained Virological Responses and Regulate Innate Immunity in Antiviral Therapy With Pegylated Interferon-Alpha. 2021 1
2 34960758 Synergistic Interferon-Alpha-Based Combinations for Treatment of SARS-CoV-2 and Other Viral Infections. 2021 Dec 11 1
3 32024338 Thyroid disturbances in children treated with combined pegylated interferon-alpha and ribavirin for chronic hepatitis C. 2020 Feb 1
4 32346535 Hepatocellular Carcinoma Mechanisms Associated with Chronic HCV Infection and the Impact of Direct-Acting Antiviral Treatment. 2020 2
5 32885325 A decrease in hepatitis C virus RNA to undetectable levels in chronic hepatitis C patients after PegIFNα + RVB or sofosbuvir + NS5A inhibitor treatment is associated with decreased insulin resistance and persistent oxidative stress. 2020 Dec 1
6 30450781 Dynamic changes in innate immune responses during direct-acting antiviral therapy for HCV infection. 2019 Mar 2
7 31081724 Association of Autoantibody to Rods and Rings with Hepatitis C Outcome and Viral Load. 2019 Jun 1
8 31640596 Molecular characterization of hepatitis C virus in liver disease patients in Botswana: a retrospective cross-sectional study. 2019 Oct 22 1
9 31685739 [QOL Assessment in Chronic Hepatitis C Patients Receiving Ledipasvir/ Sofosbuvir or Simeprevir/Peginterferon/Ribavirin in Clinical Practice]. 2019 1
10 29272349 Hepatitis C in Patients With Minimal or No Hepatic Fibrosis: The Impact of Treatment and Sustained Virologic Response on Patient-Reported Outcomes. 2018 May 17 1
11 29293991 Hepatitis C Virus-Infected Patients Receiving Opioid Substitution Therapy Experience Improvement in Patient-Reported Outcomes Following Treatment With Interferon-Free Regimens. 2018 Mar 13 2
12 29540601 Positive Regulation of Hepatitis E Virus Replication by MicroRNA-122. 2018 Jun 1 3
13 29559835 Persistent Hepatic Inflammation Plays a Role in Hepatocellular Carcinoma After Sustained Virological Response in Patients with HCV Infection. 2018 1
14 29664167 Clinical outcomes of current medical approaches for Middle East respiratory syndrome: A systematic review and meta-analysis. 2018 May 1
15 29851985 Reduced ITPase activity and favorable IL28B genetic variant protect against ribavirin-induced anemia in interferon-free regimens. 2018 6
16 29920131 Expression of SOCS1 and SOCS3 Genes in Interferon-Treated and Direct-Acting Antiviral Drugs-Treated Hepatitis C Patients. 2018 Jun 1
17 30063745 Real life rates of sustained virological response (SVR) and predictors of relapse following DAA treatment in genotype 3 (GT3) patients with advanced fibrosis/cirrhosis. 2018 1
18 30116347 Psychiatric side effects of pegylated interferon-α and ribavirin therapy in Iranian patients with chronic hepatitis C: A meta-analysis. 2018 Aug 1
19 27027531 IFNL4 polymorphism effects on outcome of simeprevir, peginterferon, and ribavirin therapy for older patients with genotype 1 chronic hepatitis C. 2017 Mar 1
20 27896573 Greater decline in memory and global neurocognitive function in HIV/hepatitis C co-infected than in hepatitis C mono-infected patients treated with pegylated interferon and ribavirin. 2017 Apr 1
21 28036111 Hepatic IFNL4 expression is associated with non-response to interferon-based therapy through the regulation of basal interferon-stimulated gene expression in chronic hepatitis C patients. 2017 Jul 1
22 28125694 Sofosbuvir in Combination with Simeprevir +/- Ribavirin in Genotype 4 Hepatitis C Patients with Advanced Fibrosis or Cirrhosis: A Real-World Experience from Belgium. 2017 1
23 28233734 Aplastic Anemia and Severe Myelosuppression with Boceprevir or Simeprevir-Containing Hepatitis C Virus Treatment. 2017 March-April 1
24 28315743 Treatment with PEG-IFN and ribavirin in patients with chronic hepatitis C, low grade of hepatic fibrosis, genotype 1 and 4 and favorable IFNL3 genotype: A pharmacogenetic prospective study. 2017 Jul 2
25 28496530 Assessment of the Relation Between SNP in MxA Gene and the Responsiveness of Egyptian HCV Genotype 4 Patients to Pegylated Interferon and Ribavirin Treatment. 2017 Apr 1
26 28506030 Simeprevir-Based Triple Therapy with Reduced Doses of Pegylated Interferon α-2a Plus Ribavirin for Interferon Ineligible Patients with Genotype 1b Hepatitis C Virus. 2017 Jul 15 1
27 29039351 Epidemiology, risk factors and prognosis of Interferon alpha induced thyroid disorders. A Prospective Clinical Study. 2017 Sep 25 1
28 29733167 [Cytopenias and their correction during antiviral therapy of chronic hepatitis C in patients with genotype 1]. 2017 1
29 26082258 Ribavirin restores IFNα responsiveness in HCV-infected livers by epigenetic remodelling at interferon stimulated genes. 2016 Apr 11
30 26750805 Sustained viral response and treatment-induced cytopenia correlate with SLCs and KLF12 genotypes in interferon/ribavirin-treated Chinese chronic hepatitis C patients. 2016 Aug 1
31 26787701 Antiviral Activities of Different Interferon Types and Subtypes against Hepatitis E Virus Replication. 2016 Apr 1
32 26825683 Patient-Reported Outcomes of Elderly Adults with Chronic Hepatitis C Treated with Interferon- and Ribavirin-Free Regimens. 2016 Feb 2
33 26921346 IFN-α promotes rapid human Treg contraction and late Th1-like Treg decrease. 2016 Sep 2
34 26945356 Patient-reported Outcomes in Asian Patients With Chronic Hepatitis C Treated With Ledipasvir and Sofosbuvir. 2016 Mar 1
35 27170384 Challenges in Special Populations: HIV/HCV Coinfection, Liver Transplantation and Patients with End-Stage Renal Disease. 2016 1
36 27275462 Ophthalmological side effects of interferon therapy of chronic hepatitis C. 2016 Jun 2
37 27376688 Optimisation of triple therapy for patients with chronic hepatitis C: a systematic review. 2016 Aug 2
38 27399090 Interferon-free regimens improve health-related quality of life and fatigue in HIV/HCV-coinfected patients with advanced liver disease: A retrospective study. 2016 Jul 1
39 27857890 Prevalence of thyroid disorders in hepatitis C virus positive patients on interferon and antiviral therapy. 2016 Oct-Dec 2
40 24961662 Simeprevir (TMC435) once daily with peginterferon-α-2b and ribavirin in patients with genotype 1 hepatitis C virus infection: The CONCERTO-4 study. 2015 May 1
41 25382001 Baseline sensitivity of T cells to alpha-IFN correlates with sustained virological response to IFN-based triple therapy in HCV infection. 2015 Jun 1
42 25445343 Influence of amino acid variations in the NS3, NS4A and NS4B of HCV genotypes 1a, 1b, 3a, 3b and 6f on the response to pegylated interferon and ribavirin combination therapy. 2015 Jan 22 1
43 25501286 Association of serum IFN-λ3 with inflammatory and fibrosis markers in patients with chronic hepatitis C virus infection. 2015 Aug 6
44 25515861 Genome-wide association study identifies a PSMD3 variant associated with neutropenia in interferon-based therapy for chronic hepatitis C. 2015 Mar 1
45 25529083 How to optimize current therapy in hepatitis C virus genotype 1 patients. Predictors of response to interferon-based therapy with second wave direct acting antivirals. 2015 Jan 2
46 25583751 SLC29A1 polymorphism and prediction of anaemia severity in patients with chronic hepatitis C receiving triple therapy with telaprevir. 2015 Apr 2
47 25624738 Simeprevir with peginterferon and ribavirin induced interstitial pneumonitis: first case report. 2015 Jan 21 1
48 25650729 Peg-IFN and ribavirin treatment for recurrence of genotype 2 and 3 hepatitis C after liver transplantation. 2015 Apr 1
49 25914454 Management of hepatitis C infection before and after liver transplantation. 2015 Apr 21 2
50 25920094 From non-A, non-B hepatitis to hepatitis C virus cure. 2015 Apr 1